Q6GI75 (FABI_STAAR) Staphylococcus aureus (strain MRSA252)

Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI UniProtKBInterProInteractive Modelling

256 aa; Sequence (Fasta) ; 13 identical sequences

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of Staphylococcus aureus enoyl-ACP reductase in complex with NADP and AFN-1252homo-4-mer1-256
0WD;0WE;
Assess
Crystal structure of S. aureus FabI in complex with NADPH and CG400549homo-4-mer1-256
SO4;NDP;PT6;EDO;CL;
Assess
Crystal structure of the staphylococcus aureus enoyl-acyl carrier protein reductase (fabI) in compl…homo-4-mer1-256
NAP;TCL;
Assess
Crystal structure of S. aureus FabI (P43212)homo-4-mer1-256
13×SO4;
Assess
Crystal Structure of the Staphylococcus aureus Enoyl-Acyl Carrier Protein Reductase (FabI) in apo f…homo-4-mer1-256
NA;
Assess
Crystal Structure of the Staphylococcus aureus Enoyl-Acyl Carrier Protein Reductase (FabI) in apo f…homo-4-mer1-256
Assess
Crystal structure of S. aureus FabI in complex with NADP and triclosan (P212121)homo-4-mer1-256
TCL;NAP;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-ethyl- 2-phenoxyphenolhomo-4-mer2-256
NAP;E9P;GLU;
Assess
Crystal structure of S. aureus FabI in complex with NADP and triclosan (P1)homo-4-mer2-256
NAP;TCL;GLU;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-hexyl- 2-phenoxyphenolhomo-4-mer2-256
GLU;NAP;6PN;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 2- phenoxy-5-(2-propenyl)phenolhomo-4-mer2-256
NAP;W1G;GLU;
Assess
Crystal structure of S. aureus FabI in complex with NADPH and CG400549 (small unit cell)homo-4-mer2-256
NDP;PT6;SO4;EDO;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-chloro- 2-phenoxyphenolhomo-4-mer2-256
NAP;GLU;CH8;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-pentyl- 2-phenoxyphenolhomo-4-mer2-256
5PP;NAP;GLU;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 2-(2- aminophenoxy)-5-hexylphenolhomo-4-mer2-256
GLU;P1F;NAP;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 2-(2- cyanophenoxy)-5-hexylphenolhomo-4-mer2-256
GLU;JUS;NAP;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 2- phenoxy-5-propylphenolhomo-4-mer2-256
GLU;NAP;PV4;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-hexyl- 2-(2-methylphenoxy)phenolhomo-4-mer2-256
TCU;NAP;GLU;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-methyl- 2-phenoxyphenolhomo-4-mer2-256
MJ5;GLU;NAP;
Assess
Crystal structure of S. aureus FabI in complex with NADP and 5-fluoro- 2-phenoxyphenolhomo-4-mer2-256
NAP;FPL;GLU;
Assess
Crystal structure of S. aureus FabI in complex with NADPH and kalimantacin A (batumin)homo-4-mer3-256
NDP;KAL;
Assess
Crystal structure of S. aureus FabI in complex with NADPH and kalimantacin Bhomo-4-mer3-256
NDP;N5H;
Assess
Crystal structure of S. aureus FabI in complex with NADPH and PT173homo-4-mer3-256
AEW;NDP;SO4;
Assess
Crystal structure of S. aureus FabI (P32)homo-4-mer3-255
Assess
Crystal Structure of FabI from S. aureus in complex with a novel benzimidazole inhibitorhomo-2-mer2-256
1JT;NAP;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4all.1.Ahomo-4-mer0.851-256
TCL;NAP;100.00
Assess
4bb6.1.Ahomo-2-mer0.572-253
16.26
Assess